CAT.one SM

CAT.one SM
Product Description

CAT.one SM minimizes the potential for abuse by ensuring that drug products are evaluated for all potential routes of misuse. Adare’s experts integrate abuse-deterrent testing by replicating basic and multi-step methods that an abuser may use to prepare the product for recreational misuse or abuse. Our CAT.one laboratory scientists possess the expertise and knowledge of current FDA Guidance on the evaluation of abuse-deterrent and manipulation-resistant formulations, allowing us to efficiently handle all your category 1 in-vitro testing needs.

Adare Pharma Solutions

  • US
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Out-licensing specialist
Packaging & drug delivery

Adare Pharma Solutions

  • US
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Out-licensing specialist
Packaging & drug delivery

More Products from Adare Pharma Solutions (13)

  • Parvulet® Technology - Patient Centric Dosing Solution

    Product Parvulet® Technology - Patient Centric Dosing Solution

    Adare has recently launched a new patient centric dosage solution, the Parvulet TM Technology. The Parvulet TM Technology enables a solid powder or tablet to convert to a semi-solid in the presence of water within thirty seconds. The final dosage is easily administered, as a soft food like texture, ide...
  • AdvaTab® Orally Disintegrating Tablets (ODTs)

    Product AdvaTab® Orally Disintegrating Tablets (ODTs)

    AdvaTab® Orally Disintegrating Tablets (ODTs) incorporates coated or uncoated drug particles that are uniformly dispersed in a low-moisture, rapidly disintegrating matrix. Each ODT is formulated to achieve an acceptable taste and desired release profile. AdvaTab® technology is ideal for patients who ha...
  • Diffucaps® Customized Release Technology

    Product Diffucaps® Customized Release Technology

    Diffucaps® Customized Release Technology has the flexibility to incorporate functional, release-controlling polymers or protective coatings onto drug-layered cores, granules, or crystals. This allows for easy adjustment of both dosage strength and dissolution profile to achieve the desired in vivo phar...
  • Microcaps® Taste Masking Technology

    Product Microcaps® Taste Masking Technology

    Microcaps® Taste Masking Technology achieves uniform and efficient coating of drug particles by a combination of coacervation (phase separation) and spray coating to build polymeric membranes of varying porosity and thickness. The completely encapsulated particle allows for a pleasant mouthfeel wi...
  • MMTS (TM) Multi Mini Tablet System Customized Release Technology

    Product MMTS (TM) Multi Mini Tablet System Customized Release Technology

    MMTS TM Multi Mini Tablet System Customized Release Technology combines the simplicity of a tablet formulation with the flexibility of multiparticulate dosage forms with high drug-loading capability. Adare has developed Ultra Microtablets—a smaller standard of tablets targeting diameters in the range o...
  • Adaptdose™

    Product Adaptdose™

    Adaptdose™, Adare’s unique commercialized approach to adaptive formulation design, is a highly flexible, multi-delivery platform tool that eliminates the need for post Phase 1 trial reformulations and facilitates the creation of custom oral delivery systems. Adaptdose provides the ability to combine 2-3 ac...
  • DIFFUTAB® Technology

    Product DIFFUTAB® Technology

    DIFFUTAB® technology is an effective solution for targeted drug delivery through customized and sustained release. The technology assists the development of high-dosage and sustained release products for once-daily administration. A matrix tablet is coated with functional polymers, followed by a blend of h...
  • Duragran™

    Product Duragran™

    Duragran™ allows for more uniformity and precise control of targeted particle sizes while providing production time and cost savings. It eliminates the need for extrusion and spheronization for high API-loaded drug particulates by using fluid bed processing technology that combines the particle sizing and ...
  • Microcaps® Taste Masking and Modified Release Technology

    Product Microcaps® Taste Masking and Modified Release Technology

    Microcaps® Taste Masking and Modified Release Technology achieves uniform and efficient coating of drug particles by coacervation (phase separation) to build polymeric membranes of varying porosity and thickness. The result is a free-flowing powder containing microencapsulated API (or API substrate) in a w...
  • Precision Particle Fabrication™ Technology

    Product Precision Particle Fabrication™ Technology

    Precision Particle Fabrication™ technology produces uniform microspheres and microcapsules with narrow size distribution and precise control over particle structure. The platform technology is flexible and customizable to accommodate a broad range of active ingredients, including small molecules, peptides ...
  • Optimµm® Technology for Oral Delivery

    Product Optimµm® Technology for Oral Delivery

    The Optimµm® technology creates microspheres with high drug loading suitable for taste masking, enteric coatings, and extended release oral applications. The technology is capable of producing single- or double-layer particles in a one manufacturing step, lending to cost-effective creation of palatabl...
  • Stratµm™ Technology for Injectable Delivery

    Product Stratµm™ Technology for Injectable Delivery

    The Stratµm™ technology, for injectable delivery, allows for precise control of particle size and composition enabling predictable injectable performance, which is critical for self-administration, extended release, and modified release applications with a narrow therapeutic index. Unlike other encapsu...

Adare Pharma Solutions resources (26)